Literature DB >> 8300631

Comparison of myristoyl-CoA:protein N-myristoyltransferases from three pathogenic fungi: Cryptococcus neoformans, Histoplasma capsulatum, and Candida albicans.

J K Lodge1, R L Johnson, R A Weinberg, J I Gordon.   

Abstract

Myristoyl-CoA:protein N-myristoyltransferase (Nmt) transfers myristate from CoA to the N-terminal Gly residue of cellular proteins in an ordered reaction mechanism that first involves binding of myristoyl-CoA to the apoenzyme. The gene encoding Saccharomyces cerevisiae Nmt1p (NMT1) is essential for vegetative growth. Candida albicans, Cryptococcus neoformans var. neoformans, and Histoplasma capsulatum are the principal causes of systemic fungal infections in immunocompromised humans. Metabolic labeling studies indicate that they synthesize a small set of cellular N-myristoylproteins during exponential growth on rich media, the most prominent of which co-migrate with two essential functionally interchangeable S. cerevisiae N-myristoylproteins, ADP ribosylation factor-1 (Arf1p) and Arf2p. NMT and ARF genes have been recovered from C. neoformans and H. capsulatum using the polymerase chain reaction. They are single copy genes, interrupted by multiple introns. C. neoformans and H. capsulatum Nmts have approximately 50% amino acid sequence identity with the orthologous S. cerevisiae, C. albicans, and Homo sapiens N-myristoyltransferases, whereas C. neoformans and H. capsulatum Arfs are approximately 80% identical with C. albicans Arf and S. cerevisiae Arf1p and Arf2p. Functional studies of C. neoformans and C. albicans Nmts conducted in Escherichia coli reveal that (i) both efficiently acylate S. cerevisiae Arf2p; (ii) C. neoformans Arf is a substrate for C. neoformans Nmt; and (iii) substitution of an Asp for a Gly located 5 residues from the C terminus of these two enzymes causes marked temperature-dependent reductions in their catalytic efficiency, just as it does with S. cerevisiae and H. sapiens Nmts. Wild type C. neoformans, C. albicans, and H. sapiens NMTs can fully complement the lethal phenotype of a S. cerevisiae nmt1 null allele at 24 and 37 degrees C when the GAL1-10 promoter controlling their expression is induced by galactose. Only the C. albicans enzyme is able to do so when the promoter is repressed with glucose. This complementation profile likely arises, at least in part, from differences in the protein substrate specificities of the orthologous Nmts. A Gly-->Asp mutation in S. cerevisiae, C. neoformans, C. albicans, and H. sapiens Nmts produces temperature-sensitive growth arrest in isogenic S. cerevisiae strains with a nmt1 null allele. Growth of strains producing the mutant C. albicans or H. sapiens, but not the C. neoformans, enzyme can be rescued by myristate at the non-permissive temperature (37 degrees C) even in the presence of cerulenin, an inhibitor of fatty acid synthetase.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8300631

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  28 in total

Review 1.  Antifungal agents: chemotherapeutic targets and immunologic strategies.

Authors:  N H Georgopapadakou; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

Review 2.  All about that fat: Lipid modification of proteins in Cryptococcus neoformans.

Authors:  Felipe H Santiago-Tirado; Tamara L Doering
Journal:  J Microbiol       Date:  2016-02-27       Impact factor: 3.422

Review 3.  N-myristoyltransferase.

Authors:  R V Rajala; R S Datla; T N Moyana; R Kakkar; S A Carlsen; R K Sharma
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

4.  Phylogenetic relationships of varieties and geographical groups of the human pathogenic fungus Histoplasma capsulatum Darling.

Authors:  T Kasuga; J W Taylor; T J White
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

5.  Coenzyme A dependent myristoylation and demyristoylation in the regulation of bovine spleen N-myristoyltransferase.

Authors:  R V Raju; R K Sharma
Journal:  Mol Cell Biochem       Date:  1996-05-24       Impact factor: 3.396

6.  Targeted gene replacement demonstrates that myristoyl-CoA: protein N-myristoyltransferase is essential for viability of Cryptococcus neoformans.

Authors:  J K Lodge; E Jackson-Machelski; D L Toffaletti; J R Perfect; J I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

7.  Characterization and selective inhibition of myristoyl-CoA:protein N-myristoyltransferase from Trypanosoma brucei and Leishmania major.

Authors:  Chrysoula Panethymitaki; Paul W Bowyer; Helen P Price; Robin J Leatherbarrow; Katherine A Brown; Deborah F Smith
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

8.  Recombinant bovine spleen myristoyl CoA: protein N-myristoyltransferase.

Authors:  R V Raju; R S Datla; R Kakkar; R K Sharma
Journal:  Mol Cell Biochem       Date:  1998-12       Impact factor: 3.396

9.  Protein myristoylation in health and disease.

Authors:  Megan H Wright; William P Heal; David J Mann; Edward W Tate
Journal:  J Chem Biol       Date:  2009-11-07

10.  N-myristoyltransferase from Leishmania donovani: structural and functional characterisation of a potential drug target for visceral leishmaniasis.

Authors:  James A Brannigan; Barbara A Smith; Zhiyong Yu; Andrzej M Brzozowski; Michael R Hodgkinson; Asher Maroof; Helen P Price; Franziska Meier; Robin J Leatherbarrow; Edward W Tate; Deborah F Smith; Anthony J Wilkinson
Journal:  J Mol Biol       Date:  2009-12-28       Impact factor: 5.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.